NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 201 filers reported holding NEVRO CORP in Q1 2022. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $396,554 | +19.1% | 10,014 | +31.7% | 0.00% | 0.0% |
| Q2 2022 | $333,000 | -45.0% | 7,605 | -9.2% | 0.00% | -50.0% |
| Q1 2022 | $606,000 | +42.6% | 8,373 | +59.6% | 0.00% | 0.0% |
| Q4 2021 | $425,000 | -26.7% | 5,246 | +5.3% | 0.00% | 0.0% |
| Q3 2021 | $580,000 | -63.9% | 4,980 | -48.6% | 0.00% | -71.4% |
| Q2 2021 | $1,606,000 | +94.2% | 9,685 | +63.5% | 0.01% | +75.0% |
| Q1 2021 | $827,000 | – | 5,925 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 403,424 | $46,950,000 | 6.74% |
| HealthCor Management, L.P. | 529,230 | $61,592,000 | 2.66% |
| Sante Capital Fund, LP | 18,963 | $2,207,000 | 2.04% |
| Jackson Square Partners, LLC | 2,452,497 | $285,421,000 | 1.81% |
| Altium Capital Management LP | 51,000 | $5,935,000 | 1.56% |
| Rock Springs Capital Management LP | 635,700 | $73,983,000 | 1.56% |
| PFM Health Sciences, LP | 392,786 | $45,712,000 | 1.34% |
| Redmile Group, LLC | 542,932 | $63,186,000 | 1.10% |
| Connacht Asset Management LP | 13,555 | $1,578,000 | 1.02% |
| Integral Health Asset Management, LLC | 30,000 | $3,491,000 | 1.00% |